623 related articles for article (PubMed ID: 29214585)
1. Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.
Low LA; Tagle DA
Adv Exp Med Biol; 2017; 1031():405-415. PubMed ID: 29214585
[TBL] [Abstract][Full Text] [Related]
2. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
3. Organs-on-a-Chip.
Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
[TBL] [Abstract][Full Text] [Related]
4. Tissue Chips to aid drug development and modeling for rare diseases.
Low LA; Tagle DA
Expert Opin Orphan Drugs; 2016; 4(11):1113-1121. PubMed ID: 28626620
[TBL] [Abstract][Full Text] [Related]
5. Tissue chips - innovative tools for drug development and disease modeling.
Low LA; Tagle DA
Lab Chip; 2017 Sep; 17(18):3026-3036. PubMed ID: 28795174
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
7. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.
Donoghue L; Nguyen KT; Graham C; Sethu P
Micromachines (Basel); 2021 Jan; 12(2):. PubMed ID: 33525451
[TBL] [Abstract][Full Text] [Related]
8. Tackling rare diseases: Clinical trials on chips.
Blumenrath SH; Lee BY; Low L; Prithviraj R; Tagle D
Exp Biol Med (Maywood); 2020 Jul; 245(13):1155-1162. PubMed ID: 32397761
[TBL] [Abstract][Full Text] [Related]
9. The Emergence of Microphysiological Systems (Organs-on-chips) as Paradigm-changing Tools for Toxicologic Pathology.
Rudmann DG
Toxicol Pathol; 2019 Jan; 47(1):4-10. PubMed ID: 30407146
[TBL] [Abstract][Full Text] [Related]
10. Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
Monteduro AG; Rizzato S; Caragnano G; Trapani A; Giannelli G; Maruccio G
Biosens Bioelectron; 2023 Jul; 231():115271. PubMed ID: 37060819
[TBL] [Abstract][Full Text] [Related]
11. Pumped and pumpless microphysiological systems to study (nano)therapeutics.
Lee EJ; Krassin ZL; Abaci HE; Mahler GJ; Esch MB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1911. PubMed ID: 37464464
[TBL] [Abstract][Full Text] [Related]
12. A human-on-a-chip approach to tackling rare diseases.
de Mello CPP; Rumsey J; Slaughter V; Hickman JJ
Drug Discov Today; 2019 Nov; 24(11):2139-2151. PubMed ID: 31412288
[TBL] [Abstract][Full Text] [Related]
13. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
14. Microphysiological Systems: Design, Fabrication, and Applications.
Wang K; Man K; Liu J; Liu Y; Chen Q; Zhou Y; Yang Y
ACS Biomater Sci Eng; 2020 Jun; 6(6):3231-3257. PubMed ID: 33204830
[TBL] [Abstract][Full Text] [Related]
15. Imaging microphysiological systems: a review.
Peel S; Jackman M
Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
[TBL] [Abstract][Full Text] [Related]
16. Human organ chips for regenerative pharmacology.
Goyal G; Belgur C; Ingber DE
Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
[TBL] [Abstract][Full Text] [Related]
17. The NIH microphysiological systems program: developing in vitro tools for safety and efficacy in drug development.
Tagle DA
Curr Opin Pharmacol; 2019 Oct; 48():146-154. PubMed ID: 31622895
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Human Body on Microfluidic Chips.
Jalili-Firoozinezhad S; Miranda CC; Cabral JMS
Trends Biotechnol; 2021 Aug; 39(8):838-852. PubMed ID: 33581889
[TBL] [Abstract][Full Text] [Related]
19. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
Hargrove-Grimes P; Low LA; Tagle DA
Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
[TBL] [Abstract][Full Text] [Related]
20. Organs-on-chips: Progress, challenges, and future directions.
Low LA; Tagle DA
Exp Biol Med (Maywood); 2017 Oct; 242(16):1573-1578. PubMed ID: 28343437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
